STAT3 mediates RCP-induced cancer cell invasion through the NF-κB/Slug/MT1-MMP signaling cascade

Su Jin Cho1, Bo Young Jeong1,2, Young Soo Song3

  • 1Department of Pharmacology, College of Medicine, Konyang University, 821 Medical Science Building, 158 Gwanjeodong-ro, Seo-gu, Daejeon, 35365, Republic of Korea.

Insights

Rab coupling protein (RCP) drives cancer invasion by activating STAT3 signaling. Inhibiting STAT3 blocks RCP-induced metastasis, revealing a key pathway for therapeutic targeting in ovarian and breast cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Rab coupling protein (RCP) is implicated in cancer invasion and metastasis.
  • Signal transducer and activator of transcription 3 (STAT3) is a known oncogenic factor involved in cancer progression.

Purpose of the Study:

  • To elucidate the critical role of STAT3 in RCP-induced cancer cell invasion.
  • To investigate the molecular mechanisms linking RCP, STAT3, and cancer metastasis.

Main Methods:

  • Immunohistochemistry on ovarian cancer tissues to correlate RCP and phospho-STAT3 (p-STAT3) expression.
  • In vitro studies involving cancer cell lines to assess RCP's effect on STAT3 phosphorylation.
  • Gene silencing and pharmacological inhibition of STAT3 to evaluate its impact on invasion.
  • Analysis of the β1 integrin/EGFR axis and downstream signaling pathways including NF-κB, Slug, and MT1-MMP.

Main Results:

  • High RCP and p-STAT3 expression correlated with lower survival rates in ovarian cancer patients.
  • RCP induced STAT3 phosphorylation in ovarian and breast cancer cells.
  • STAT3 inhibition significantly reduced RCP-induced cancer cell invasion.
  • The β1 integrin/EGFR axis was identified as crucial for RCP-induced STAT3 phosphorylation.
  • STAT3 activation of NF-κB led to Slug and MT1-MMP upregulation, promoting invasion.

Conclusions:

  • STAT3 is a critical mediator of RCP-induced cancer invasion and metastasis.
  • The β1 integrin/EGFR/STAT3/NF-κB/Slug/MT1-MMP axis represents a key pathway in RCP-driven cancer progression.
  • Targeting STAT3 may offer a therapeutic strategy against RCP-mediated invasion and metastasis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K